News

Crescent Capital BDC Announces Strong Earnings and Dividends

Crescent Capital BDC Announces Strong Earnings and Dividends

Crescent Capital BDC Reports Fourth Quarter Earnings

Today, Crescent Capital BDC, Inc. (CCAP) unveiled its financial results for the fourth quarter of the year, reflecting strong earnings performance and effective capital allocation strategies. The firm reported a remarkable net investment income of $2.40 per share for the full year, while fourth-quarter net investment income stood at $0.55 per share. This achievement underscores Crescent's robust operational framework and commitment to its stakeholders.

Key Financial Highlights

Performance Metrics

As of the end of the reporting period, Crescent's net asset value (NAV) per share was recorded at $19.98. The total assets managed by the firm amounted to approximately $1.66 billion, reflecting a steady growth trajectory. The increase in assets can be attributed to strategic investments, which remain the core focus of Crescent's operational strategy.

Dividend Announcement

The Board of Directors has declared a quarterly cash dividend of $0.42 per share for the first quarter, demonstrating Crescent's strong cash flow generation capabilities. Additionally, the company announced a series of special cash dividends amounting to $0.15 per share, distributed over three installments. These dividends not only represent a rewarding return for stockholders but also affirm Crescent's ongoing commitment to delivering shareholder value.

Portfolio and Investment Activities

Investment Landscape

As of December 31, 2024, Crescent Capital BDC maintained investments in 185 portfolio companies with a fair value total of approximately $1.6 billion. This diverse portfolio illustrates Crescent’s strategic focus on sectors with sustainable growth potential, bolstered by sound business practices.

Investment Trends in 2024

The company demonstrated aggressive investment activity during the reporting period, deploying $395.0 million across various new and existing portfolio ventures. This strategic move reflects management’s confidence in the growth potential of its investment verticals and its focus on supporting innovative businesses.

Operational Results

Income Generation Overview

For 2024, Crescent reported a total investment income increase to $197.4 million, up from $184.1 million in the previous year. The growth in interest income, partially due to a robust investment portfolio, was pivotal in achieving this increase. Despite a slight decrease in dividend income, other income streams showed marked improvement, demonstrating the benefits of Crescent's diversified income-generating assets.

Expense Management

While investment income climbed, total expenses also grew to $108.4 million, reflecting increased interest and administrative costs associated with its growing asset base. The diligent management of these expenses remains a priority as the company seeks to optimize its operational efficiency.

Liquidity and Financial Position

Cash Reserves

Crescent Capital BDC reported having approximately $39.4 million in cash and equivalents, combined with a substantial undrawn capacity of $337.5 million on its credit facilities, which positions it well for future investments and strategic opportunities.

Conference Call Information

For those interested in further details, Crescent Capital will hold a conference call, where management and analysts will delve deeper into the financials and strategic outlook. Interested parties can find details on its Investor Relations page.

About Crescent Capital BDC

Crescent Capital BDC is committed to maximizing shareholder returns via a strategic approach to capital investment in middle-market companies. Its management team, backed by decades of experience, ensures focused efforts on identifying and nurturing high-potential investment opportunities.

Frequently Asked Questions

What is the reported net income per share for Crescent Capital BDC?

The reported net income per share for Crescent Capital BDC for the full year is $2.40.

How much is the declared dividend for the first quarter?

The declared dividend for the first quarter is $0.42 per share.

How many portfolio companies does Crescent Capital BDC invest in?

Crescent Capital BDC has investments in 185 portfolio companies.

What was the total investment income reported for 2024?

The total investment income reported for 2024 was $197.4 million.

How much cash and equivalents does Crescent Capital BDC have?

Crescent Capital BDC reported approximately $39.4 million in cash and cash equivalents.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Acepodia's ACE723 Clears FDA Hurdle for Hepatocellular Push

Updated Category News Views 3

Unexpected Developments from Acepodia Folks keeping a keen eye on the biotech scene might just raise an eyebrow at Acepodia's latest move. The FDA has given their nod to ACE723, an ambitious dual-payload antibody-drug conjugate (ADC) designed to wrangle with those stubborn cases of unresectable or metastatic hepatocellular carcinoma (HCC). This isn't just another day in...

Continue Reading
CRESYN Opens Model Residence: A Peek at City Living

Updated Category News Views 2

CRESYN: Urban Elegance Hits Long Island City Who doesn't want to peek under the hood when a flashy new ride rolls into town? CRESYN's newly unveiled model residence in Long Island City is just that—an invitation to get up close and personal with what modern urban living can be. Forget the blueprints and glossy renderings. This place is the real deal, giving you that...

Continue Reading
Clark Pacific's Arizona Plant to Triple Output by 2027

Updated Category News Views 2

Clark Pacific's Bold Expansion You've got to admire the guts it takes to break new ground, both literally and figuratively. That's exactly what Clark Pacific is doing by launching a spanking new facility in Coolidge, Arizona. It ain't just any plant, either. We're talking about a colossal 110-acre site that'll eventually boost the company's production capacity threefold....

Continue Reading
Carestream's Enhanced DRX-LC: Imaging Game Changer

Updated Category News Views 1

Rethinking Long-Length Imaging with Carestream The medical imaging sector just got a shot in the arm with Carestream Healthcare International's latest leap in technology. The DRX?LC Detector is not just a fancy update — it's a full-on revolution for long?length imaging. Forget the old days of piecing multiple exposures together, because this innovation simplifies...

Continue Reading
Terrabis Revolutionizes Illinois with Dual-Window Dispensary

Updated Category News Views 0

Terrabis Unveils a Speedier Cannabis Experience What do you do when the world is demanding faster service? You innovate. That’s precisely what Terrabis has done by unveiling Illinois' first dual-window drive-thru dispensary in Grayville. Situated just off I-64, this facility isn't just offering a new way of doing things; it's setting the stage for what might very well...

Continue Reading
DELIVAN Unveils Electric Vans and Expansion in Europe

Updated Category News Views 2

DELIVAN Charging Forward with All-Electric Vans Mark the calendar—September 4, 2026, marked a big day for DELIVAN. The company's foray into the European market is getting serious, splashed across IAA Transportation in all its glory. Unveiling two fresh all-electric production vans, DELIVAN's not just tiptoeing onto the scene; it's diving headfirst into Europe's buzzing...

Continue Reading
Connected Retail Security: Rising Risks and Fragmented Roles

Updated Category News Views 4

Cyber Threats in the Connected Retail Landscape The retail world isn't what it used to be. Walk into a store today, and you're greeted not just by products but a web of interconnected systems screaming for attention. Sure, you've got your old-school POS systems humming along, but they're just one brittle cog in a rattling machine of IoT devices, cloud platforms, and...

Continue Reading
Argo Biopharma's BW-20805 Shows Promise in HAE Phase II Trial

Updated Category News Views 1

Argo's Gains in Hereditary Angioedema Therapy Think about it, folks – reducing a hereditary angioedema attack by over 80%? Argo Biopharma, the slick operator in the RNA therapeutics space, is flexing its muscles again. They've hauled in some impressive data for their siRNA therapeutic, BW-20805, at the 2026 Bradykinin Symposium in Berlin. For you deep-pocketed investors...

Continue Reading
Tetragon Completes $50M Tender Offer; Shares Prorated

Updated Category News Views 0

Unpacking Tetragon’s $50 Million Dutch Auction Move If you comb through the smoke-filled corridors of finance, you'll find the name Tetragon Financial Group pacing the latest tender offer rounds. They danced their way through a $50 million 'modified Dutch auction,' snapping up non-voting shares with a kind of ruthless efficiency that only seasoned market players can...

Continue Reading
PROCEPT Faces Legal Storm Over Sales Practices Missteps

Updated Category News Views 1

Investors Take Aim: A Legal Showdown on the Horizon There's a brewing storm over at PROCEPT BioRobotics—ticker NASDAQ:PRCT if you're tracking. These folks are knee-deep in a securities class action lawsuit from investors who’ve taken a financial wallop. The lawsuits are triggered by allegations of shady sales techniques that artificially bumped up their unit sales...

Continue Reading

Top 5 Most Recently Viewed Articles

Ørsted's Strategic Move: Selling Major Stake in Solar Projects

Updated Category News Views 99

Ørsted Sells 50% Stake in Solar and Battery Projects Renewable energy leader Ørsted has made headlines with its recent announcement regarding a significant divestment. The company has successfully sold a 50% equity stake in three U.S. onshore solar and battery projects to Energy Capital Partners, totaling an impressive $572 million. Overview of Divested Projects Details...

Continue Reading
Navigating Market Fluctuations Amid Inflation Concerns

Updated Category News Views 46

In a landscape where every number counts, US stock futures were down slightly in response to anticipated consumer inflation data. The Dow Jones Industrial Average futures ticked down by 0.1%, S&P 500 futures saw a dip of about 0.2%, and even the Nasdaq 100 futures took a hit with a similar drop. Traders were holding their breath after those indices had recently climbed to...

Continue Reading
CVR Partners Files Annual Report; Highlights in Fertilizer Market

Updated Category News Views 146

CVR Partners, LP Annual Report Submission CVR Partners, LP (NYSE: UAN), a leading manufacturer of ammonia and urea ammonium nitrate (UAN) solution fertilizers, has filed its annual Form 10-K report. This filing is crucial as it provides shareholders with detailed insights into the financial health and operational performance of the company over the past fiscal year....

Continue Reading
Capgemini Launches New AI Hub in Egypt for Global Clients

Updated Category News Views 548

Capgemini Launches New AI Hub in Egypt for Global Clients Capgemini has made a significant move by establishing an AI Center of Excellence (CoE) in Egypt aimed at accelerating the adoption of artificial intelligence across various industries for clients around the globe. This initiative is part of Capgemini's ongoing commitment to bolster innovation capabilities and drive...

Continue Reading
Transforming Into the AI × Web3 Era: AIxCrypto Holdings' Vision

Updated Category News Views 357

AIxCrypto Holdings: A New Chapter in Innovation In a significant development for stakeholders, Qualigen Therapeutics, Inc. (NASDAQ: QLGN) has successfully held a Special Meeting of Stockholders, where all proposals received overwhelming majority approval. This milestone marks a pivotal moment as Qualigen prepares for its transformation into AIxCrypto Holdings, Inc....

Continue Reading